Abstract:An amino‐functionalization strategy is introduced to fabricate a library of kidney‐targeting fluorophores NHcy with tunable emission ranging from NIR‐I to NIR‐II. Building on this NIR‐II kidney‐targeting platform, the first NIR‐II small‐molecule kidney‐targeting pH probe NIR‐II‐pH is developed, which exhibits a desirable kidney distribution after tail intravenous injection and achieves precise visualization of metabolic acidosis induced by cisplatin and renal I/R injury. The development of rapidly distributed and retained probes within the kidneys is important for accurately diagnosing kidney diseases. Although molecular imaging shows the potential for non‐intrusively interrogating kidney disease‐related biomarkers, the limited kidney contrast of many fluorophores, owing to their relatively low distribution in the kidney, hinders their effectiveness for kidney disease detection. Herein, for the first time, an amino‐functionalization strategy is proposed to construct a library of kidney‐targeting fluorophores NHcy with tunable emissions from NIR‐I to NIR‐II. Among these, NHcy‐8 is the first small‐molecule NIR‐II dye without a renal clearance moiety, designed specifically for kidney‐targeting imaging. Building on this class of NIR‐II fluorophore, the first NIR‐II small‐molecule kidney‐targeting pH probe NIR‐II‐pH is developed, which exhibits a desirable kidney distribution after intravenous injection and is fluorescent only after activation by acidosis. NIR‐II in vivo fluorescence/photoacoustic imaging of kidney disease models induced by cisplatin and renal I/R injury using NIR‐II‐pH reveals increasingly severe metabolic acidosis as the disease progressed, enabling sensitive detection of the onset of acidosis 36 h (cisplatin group) earlier than clinical methods. Thus, this study introduces a practical NIR‐II kidney‐targeting probe and provides a useful molecular blueprint for guiding kidney‐targeting NIR‐II fluorophores as diagnostic aids for kidney diseases.

Near-Infrared Fluorescence Probes for Monitoring and Diagnosing Nephron-Urological Diseases

Near-infrared fluorescent molecular probes for imaging and diagnosis of nephro-urological diseases

Renal-clearable Nanoprobes for Optical Imaging and Early Diagnosis of Diseases

Engineering Cyanine‐ and Hemicyanine‐Based Probes for Optical Imaging of Kidney Diseases

Recent advances of photoresponsive nanomaterials for diagnosis and treatment of acute kidney injury

Engineering of Kidney‐Targeting Fluorophores with Tunable Emission from NIR‐I to NIR‐II for Early Diagnosis of Kidney Disease

Near-infrared Fluorescence Probes for Surgical Navigation

Advanced NIR ratiometric probes for intravital biomedical imaging

Structural and functional NIR-II fluorescence bioimaging in urinary system via clinically approved dye methylene blue

Recent advances in near-infrared II imaging technology for biological detection

Renal clearing carbon dots-based near-infrared fluorescent super-small nanoprobe for renal imaging

Optical Molecular Probes for Imaging and Early Diagnosis of Acute Kidney Injury

An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury

Activity-Based NIR Enzyme Fluorescent Probes for the Diagnosis of Tumors and Image-Guided Surgery.

Near‐Infrared Chemiluminescent Reporters for In Vivo Imaging of Reactive Oxygen and Nitrogen Species in Kidneys

A Promising NIR‐II Fluorescent Sensor for Peptide‐Mediated Long‐Term Monitoring of Kidney Dysfunction

Second Near-Infrared Window Fluorescence Nanoprobes for Deep-Tissue in Vivo Multiplexed Bioimaging.

Near-infrared-II Fluorescence Imaging for Tumor Diagnosis and Therapy

Developing A Bright Nir-Ii Fluorophore With Fast Renal Excretion And Its Application In Molecular Imaging Of Immune Checkpoint Pd-L1

Bright and Renal-Clearable Au Nanoclusters with NIR-II Excitation and Emission for High-Resolution Fluorescence Imaging of Kidney Dysfunction

Near-infrared fluorophores for biomedical imaging